Are Magnetic Resonance Findings Predictive of Clinical Outcome in Therapeutic Trials in Multiple Sclerosis? The Dilemma of Interferon-beta
Overview
Authors
Affiliations
Mind the gap: from neurons to networks to outcomes in multiple sclerosis.
Chard D, Alahmadi A, Audoin B, Charalambous T, Enzinger C, Hulst H Nat Rev Neurol. 2021; 17(3):173-184.
PMID: 33437067 DOI: 10.1038/s41582-020-00439-8.
Outcome Measures in Clinical Trials for Multiple Sclerosis.
van Munster C, Uitdehaag B CNS Drugs. 2017; 31(3):217-236.
PMID: 28185158 PMC: 5336539. DOI: 10.1007/s40263-017-0412-5.
Neuroanatomy of pseudobulbar affect : a quantitative MRI study in multiple sclerosis.
Ghaffar O, Chamelian L, Feinstein A J Neurol. 2008; 255(3):406-12.
PMID: 18297331 DOI: 10.1007/s00415-008-0685-1.
Vavasour I, Li D, Laule C, Traboulsee A, Moore G, MacKay A J Neurol. 2007; 254(12):1653-9.
PMID: 17934875 DOI: 10.1007/s00415-007-0604-x.
Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.
Liu C, Edwards S, Gong Q, Roberts N, Blumhardt L J Neurol Neurosurg Psychiatry. 1999; 66(3):323-30.
PMID: 10084530 PMC: 1736263. DOI: 10.1136/jnnp.66.3.323.